Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.86 |
| ▸ | PLG | P00747 | 1/20 | 0.77 |
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.76 |
| ▸ | FLT3 | P36888 | 2/20 | 0.76 |
| ▸ | MAOB | P27338 | 2/20 | 0.76 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.76 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.76 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | KDM1A | O60341 | 1/20 | 0.73 |
| ▸ | XDH | P47989 | 1/20 | 0.73 |
| ▸ | IPMK | Q8NFU5 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29845342 | 1.00 | CYP1B1 (0.86) | CYP1B1PLGIP6K2FLT3MAOB | |
| Methane SCHEMBL27890494 | 0.99 | CYP1B1 (0.84) | CYP1B1PLGIP6K2FLT3MAOB | |
| SCHEMBL27907057 | 0.99 | CYP1B1 (0.84) | CYP1B1PLGIP6K2FLT3MAOB | |
| SCHEMBL30365934 | 0.92 | CYP1B1 (1.00) | CYP1B1PLGIP6K2FLT3MAOB | |
| Velutin SCHEMBL29928535 | 0.92 | CYP1B1 (0.86) | CYP1B1PLGIP6K2FLT3MAOB | |
| SCHEMBL29883103 | 0.92 | CYP1B1 (1.00) | CYP1B1PLGIP6K2FLT3MAOB | |
| Velutin SCHEMBL5804380 | 0.92 | CYP1B1 (0.86) | CYP1B1PLGIP6K2FLT3MAOB | |
| SCHEMBL2483636 | 0.92 | CYP1B1 (1.00) | CYP1B1PLGIP6K2FLT3MAOB | |
| SCHEMBL26117114 | 0.92 | CYP1B1 (0.86) | CYP1B1PLGIP6K2FLT3MAOB | |
| Tetramethylluteolin SCHEMBL29725288 | 0.88 | ABCB1 (0.80) | CYP1B1PLGCYP1A1CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117731774-A | Application of 3',4', 7-O-trimethyl luteolin in preparation of photodynamic therapy photosensitizer | 常州大学 | 2024-03-22 | — | — | CN | claimed |
| CN-116577430-A | Method for identifying wide dried orange peel with different harvest periods in different years based on metabonomics | 华南农业大学 | 2023-08-11 | — | — | CN | claimed |
| CN-117731774-A | Application of 3',4', 7-O-trimethyl luteolin in preparation of photodynamic therapy photosensitizer | 常州大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117731774-A | Application of 3',4', 7-O-trimethyl luteolin in preparation of photodynamic therapy photosensitizer | 常州大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117731774-A | Application of 3',4', 7-O-trimethyl luteolin in preparation of photodynamic therapy photosensitizer | 常州大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-104231010-A | Compound having antiviral activity and its preparation method and use | HEILONGJIANG SONGHUAJIANG PHARMACEUTICAL CO LTD | 2014-12-24 | — | — | CN | disclosed |
| CN-102879502-B | Method for identifying lonicera similis hemsl high-quality medicinal materials | UNIV CHENGDU TRAD CN MEDICINE | 2014-07-23 | — | — | CN | disclosed |
| CN-102879502-B | Method for identifying lonicera similis hemsl high-quality medicinal materials | UNIV CHENGDU TRAD CN MEDICINE | 2014-07-23 | — | — | CN | disclosed |
| CN-102924418-B | Method for separating and purifying effective ingredients from fine felt hairy honeysuckle | UNIV CHENGDU TRAD CN MEDICINE | 2014-04-02 | — | — | CN | disclosed |
| CN-102924418-A | Method for separating and purifying effective ingredients from fine felt hairy honeysuckle | UNIV CHENGDU TRAD CN MEDICINE | 2013-02-13 | — | — | CN | disclosed |
| CN-102879502-A | Method for identifying lonicera similis hemsl high-quality medicinal materials | UNIV CHENGDU TRAD CN MEDICINE | 2013-01-16 | — | — | CN | disclosed |
| CN-102879502-A | Method for identifying lonicera similis hemsl high-quality medicinal materials | UNIV CHENGDU TRAD CN MEDICINE | 2013-01-16 | — | — | CN | disclosed |
| US-20110144194-A1 | CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | AXOGLIA THERAPEUTICS (LU) | 2011-06-16 | — | — | US | disclosed |
| EP-2297127-A1 | CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | AxoGlia Therapeutics S.A. (LU) | 2011-03-23 | — | — | EP | disclosed |
| WO-2009130253-A1 | CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | AXOGLIA THERAPEUTICS S.A. (LU) | 2009-10-29 | — | — | WO | disclosed |
| EP-2112145-A1 | Chromenone derivatives useful for the treatment of neurodegenerative diseases | AxoGlia Therapeutics S.A. (LU) | 2009-10-28 | — | — | EP | disclosed |
| US-20080287374-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20060135445-A1 | Breast cancer-resistant protein inhibitor | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2006-06-22 | — | — | US | disclosed |
| EP-1591112-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | Kabushiki Kaisha Yakult Honsha (JP) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135445-A1 | Breast cancer-resistant protein inhibitor | ABCC1, BCR, BRCA1 | CYP1B1 815/4885PLG 4502/4885IP6K2 2224/4885 |
| US-20110144194-A1 | CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PARK7, CDR2, SNCA | CYP1B1 684/4885PLG 4569/4885IP6K2 3930/4885 |
| US-20080287374-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | ABCC1, BCR, BRCA1 | CYP1B1 815/4885PLG 4502/4885IP6K2 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.